Sanofi-Santhelabo Korea breaks 100 billion barrier in 2003 revenue

Sanofi-Santhelabo Korea said it hit a 100 billion barrier last year for the first time since its foundation in Korea. In terms of sales revenue, the company advanced into 20th place from 100th rank six years ago.

The pharmaceutical maker aims to achieve more 4 percent of the domestic market share by the year 2010 and plans to set up a CRU unit so as to participate in the headquarters' clinic...